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Abstract: 
Juvenile female and male (young) and 16-mo-old male (old) rats inhaled manganese in the form of manganese 
sulfate (MnSO4) at 0, 0.01, 0.1, and 0.5 mg Mn/m
3
 or manganese phosphate at 0.1 mg Mn/m
3
 in exposures of 6 
h/d, 5 d/wk for 13 wk. We assessed biochemical end points indicative of oxidative stress in five brain regions: 
cerebellum, hippocampus, hypothalamus, olfactory bulb, and striatum. Glutamine synthetase (GS) protein 
levels, metallothionein (MT) and GS mRNA levels, and total glutathione (GSH) levels were determined for all 
five regions. Although most brain regions in the three groups of animals were unaffected by manganese expo-
sure in terms of GS protein levels, there was significantly increased protein (p<0.05) in the hippocampus and 
decreased protein in the hypothalamus of young male rats exposed to manganese phosphate as well as in the 
aged rats exposed to 0.1 mg/m
3
 MnSO4. Conversely, GS protein was elevated in the olfactory bulb of females 
exposed to the high dose of MnSO4. Statistically significant decreases (p<0.05) in MT and GS mRNA as a 
result of manganese exposure were observed in the cerebellum, olfactory bulb, and hippocampus in the young 
male rats, in the hypothalamus in the young female rats, and in the hippocampus in the senescent males. Total 
GSH levels significantly (p<0.05) decreased in the olfactory bulb of manganese exposed young male rats and 
increased in the olfactory bulb of female rats exposed to manganese. Both the aged and young female rats had 
significantly decreased (p<0.05) GSH in the striatum resulting from manganese inhalation. The old male rats 
also had depleted GSH levels in the cerebellum and hypothalamus as a result of the 0.1-mg/m
3
 manganese 
phosphate exposure. These results demonstrate that age and sex are variables that must be considered when 
assessing the neurotoxicity of manganese. 




Manganese is an essential trace metal that is found in all tissues and is required for normal amino acid, lipid, 
protein, and carbohydrate metabolism (1). Although manganese deficiency is extremely rare in humans, toxicity 
resulting from manganese imbalance is much more prevalent and the brain appears to be a vulnerable organ to 
this toxicity (manganese neurotoxicity). This toxicity is associated with occupational overexposures or unusual 
exposures (e.g., contaminated well water, parenteral nutrition therapy in patients with liver disease) (2). 
 
Manganese neurotoxicity most commonly occurs in workers who have been chronically exposed to aerosols or 
dusts that contain extremely high levels (> 1–5 mg Mn/m
3
) of manganese (3–5). Currently, the focus on 
airborne manganese has increased because of the recent approval for the use of a fuel additive in some unleaded 
gasoline, the antiknock agent methylcyclopentadienyl manganese tricarbonyl (MMT), although the level of 
manganese resulting from MMT in urban areas does not exceed tolerable levels set by the governments of 
Canada and the United States (6). It has been speculated that chronic low-level manganese exposure might play 
a role in the pathogenesis of neurodegenerative disorders, especially in susceptible populations. Because of 
distinct similarities between Parkinson’s disease and manganese neurotoxicity (e.g., bradykinesia and wide-
spread rigidity), an intense pursuit of the possible role that manganese has in the etiology of Parkinson’s disease 
is underway. 
 
Oxidative stress has been implicated as a contributing mechanism by which manganese might be cytotoxic (7). 
The oxidation of dopamine by manganese is a potential mechanism invoked for manganese-induced oxidative 
stress, especially because manganese accumulates in dopamine-rich brain regions of rodents and primates (e.g., 
basal ganglia) (8). Another possible mechanism is that manganese, through its sequestration in mitochondria, 
interferes with proper respiration, thereby leading to excessive production of reactive oxygen species. One 
laboratory reported inhibition of complex I of the electron-transport chain after treatment of PC12 cell cultures 
with MnCl2 (9). Another laboratory showed evidence suggesting that the ATPase complex is inhibited at very 
low levels of mitochondrial manganese and that complex I is inhibited only at higher manganese concentrations 
(10). It has been shown that trivalent manganese is more effective in inhibiting complex I (11–13), but the 
divalent form is by far the predominant species within cells and is largely bound to ATP (12,14). Nevertheless, 
in biological media, manganese of any valence will spontaneously give rise to infinitesimal amounts of trivalent 
manganese, and HaMai et al. (15) demonstrated that even at trace amounts, trivalent manganese can cause 
formation of reactive oxygen species. Finally, a recent report showed that exposure of cells to MMT resulted in 
rapid increases in reactive oxygen species followed by mitochondrially induced apoptosis (16). However, 
because combustion of MMT in cars yields various manganese salts, the most abundant being phosphate and 
sulfate (17,18), direct exposure of cells to MMT does not represent a toxicologically relevant experimental 
model. 
 
Our laboratory recently reported the effect of manganese exposure (both orally administered and airborne) on 
oxidative stress end points in young male rats (19,20). These rats were exposed to 0, 0.03, 0.3, and 3.0 mg 
Mn/m
3
 manganese sulfate for 14 d, representing doses three times higher than in this current study but for a 
much shorter duration. This present study extends the previous observations by examining the interactions of 
sex and/or age and manganese exposure on end points of oxidative stress in select brain regions. It is currently 
unknown what, if any, sex-specific differences exist in the response to manganese-induced oxidative stress 
markers. Likewise, the aged brain is also relatively unexplored in terms of assessing manganese-induced 
oxidative stress. Desole et al. showed that glutathione (GSH) levels decrease in the striatum of senescent male 
rats exposed to manganese (21), but they did not measure metallothionein or glutamine synthetase, or any other 
markers of oxidative stress. Finally, the rats in the present study were exposed to lower levels of airborne man-
ganese for a longer time period (13 wk) compared to the previous studies (14 d) (19,20). Thus, the model used 
in this study, a chronic, moderate level of manganese exposure, is more representative of the type of manganese 
exposure that would affect the widest spectrum of the population, although they are hundreds to thousands of 
times higher than those among the general population of Toronto (4). 
 




) phosphate, in the mineral form hureaulite [Mn5(PO4)2[(PO3)(OH)]2·4H2O], was obtained 
from Alfa Aesar (Ward Hill, MA). The material is a reddish white fine crystalline powder, is 37.7% manganese 
by weight, and is relatively insoluble in water. Manganese(II) sulfate monohydrate (MnSO4·H2O) was obtained 
from Aldrich Chemical Company, Inc. (Milwaukee, WI). Manganese sulfate is a relatively water-soluble, 
pale pink, crystalline powder that contains 32% manganese. All other chemicals were purchased from Sigma 
Chemical (St. Louis, MO) unless otherwise noted and were of the highest possible quality. 
 
Animals 
Dorman et al. (22) previously detailed animal treatments and exposures. The study was conducted under federal 
guidelines for the care and use of laboratory animals (National Research Council, 1996) and was approved by 
the CIIT Institutional Animal Care and Use Committee. Young (6-wk-old) male and female CD rats were 
purchased from Charles River Laboratories, Inc. (Raleigh, NC). Senescent (≥ 16 mo old) male CD rats were 
purchased from Charles River Laboratories, Inc. (Canada). All prestudy health screens were negative. Animals 
were acclimated for approx 2 wk in a HEPA-filtered, mass air-displacement room maintained at 18.5–21.5°C 
and 40–60% relative humidity in CIIT’s AAALAC-accredited animal facility. Rats were individually housed in 
suspended stainless-steel cages (Lab Products, Inc., Seaford, DE) with an automatic watering system that 
provided reverse-osmosis purified water ad libitum. A pelleted, semipurified AIN-93G-certified diet from Bio-
Serv (Frenchtown, NJ) formulated to contain approx 10 ppm manganese and 35 ppm iron was given ad libitum 
(except during inhalation exposures) throughout the study. Fluorescent lighting was kept on a 12-h light–dark 




Rats were exposed whole body in 8-m
3
 Hinners-style, stainless-steel and glass inhalation exposure chambers 
using exposure cage rack units. Hureaulite and MnSO4 atmospheres were generated and characterized using 
methods described by Dorman et al. (22). Nominal MnSO4 exposure concentrations of 0.01, 0.1, and 0.5 mg 
Mn/m
3
 were used in this study. A single hureaulite exposure concentration of 0.1 mg Mn/m
3
 was used in this 
study. The target particle size distribution was 1.5–2 µm mass median aerodynamic diameter with a geometric 
standard deviation (GSD) < 2. Control groups were exposed to HEPA-filtered air only. All exposures were 
conducted for 6 h/d, 5 d/wk for 13 wk. 
 
Based on optical particle sensor results, the overall average concentrations (± SD) for the MnSO4 atmospheres 
were 0.01 ± 0.001, 0.098 ± 0.009, and 0.478 ± 0.042 mg/m
3
 for the target concentrations of 0.01, 0.1, and 0.5 
mg Mn/m
3
, respectively. The geometric mean diameters (GMD) and geometric standard deviations (GSD; µg) 
of the MnSO4 aerosols were determined to be 1.08 µm (µg = 1.52), 1.09 µm (µg = 1.53), and 1.12 µm (µg = 
1.56) for the target concentrations of 0.01, 0.1, and 0.5 mg Mn/m
3
, respectively. The calculated mass median 
aerodynamic diameters (MMADs) were 1.85, 1.92, and 2.03 µm for the target MnSO4 concentrations of 0.01, 
0.1, and 0.5 mg Mn/m
3
, respectively. The overall average concentration (± SEM) for the hureaulite aerosol was 
0.099 ± 0.004 mg hureaulite/m
3
 for the target concentration of 0.1 mg Mn/m
3
. The GMD and calculated 
MMAD for the hureaulite aerosol were 1.03 µm (µg = 1.41) and 1.47 µm, respectively. 
 
Tissue Collection 
At the termination of exposures, euthanasia (with CO2) was carried out in accordance with NIH guidelines. The 
brain areas of interest were dissected out and weighed, and then placed in high-purity linear polyethylene vials, 
frozen in liquid nitrogen, and stored at –80°C until analysis. 
 
RNA Isolation and Northern Blot Analysis 
The RNA tissue samples were homogenized and total RNA was extracted with a monophase phenol and 
guanidine isothiocyanate solution (RNA STAT- 60, Tel-Test, Inc., Friendswood, TX). For Northern analysis, 10 
µg of RNA were electrophoresed on a 1.2% agarose denaturing gel and transferred onto a positively charged 
nylon membrane (Nytran SuPerCharge; Schleicher & Schuell, Keene, NH) overnight by capillary transfer in 
10X SSC (1X SSC = 0.15 M sodium chloride, 0.015 M sodium citrate) buffer. The RNA was immobilized with 
an ultraviolet (UV) crosslinker. 
 
For metallothionen (MT) or glutamine synthetase (GS), the blot was prehybridized in 50% deionized 
formamide, 5X Denhardt’s solution, 10% dextran sulfate, 0.1% sodium dodecyl sulfate (SDS), 4X SSC of 100 
g/mL denatured salmon sperm DNA, and 20 mM Tris-HCl, pH 8.0 for 1 h at 45°C. To probe for MT or GS, the 
blot was prehybridized in Ultrasensitive Hybridization Buffer (Ambion, Inc., Austin, TX) at 45°C. The RNA 
blots were then hybridized overnight with 10
5
 cpm/mL of a [α-
32
P]dCTPlabeled random primed cDNA probe 
(approx 1 × 10
8
 cpm/µg; RadPrime DNA Labeling System, Gibco-BRL Life Technologies, Rockville, MD). 
Membranes were washed two to three times in 2X SSC/0.1% SDS at 45°C for 20 min, and then exposed to 
Kodak Biomax MR film, at –80°C with intensifying screens for 24–36 h. The autoradiograms were quantified 
by densitometry scanning in conjunction with the TINA v2.09e computer program (Raytest USA, Inc., 
Wilmington, NC). To correct for the total loaded RNA level, the blots were stripped in 0.1X SSC/0.1% SDS/40 
mM Tris buffer and probed for 28S rRNA (23). 
 
 
Protein Isolation and Western Blot Analysis 
Tissue lysates were centrifuged for 10 min at 10,000g to remove cellular debris, and the protein content of the 
resultant supernatant was determined with the bicinchoninic acid method (Pierce Chemical, Rockford, IL). An 
aliquot of 100 µg of protein was concentrated from the imidazole lysis buffer by organic extraction. Sample 
volumes were brought up to 400 µL with water and an equal volume of methanol (400 µL) was added, followed 
by 100 µL of chloroform. Samples were vortexed for 20 s and centrifuged at 14,000g for 3 min. The upper layer 
was removed and discarded. An additional 300 µL of methanol was added to each sample and they were again 
vortexed and centrifuged. The supernatant was removed and the pellet was air-dried. Each pellet was then 
dissolved in 100 µL of 2% SDS and heated to 65°C. 
 
Five microliters of 5X loading buffer (50% glycerol; 10% SDS, 0.25 M Tris-HCl, pH 6.8) and dithiothreitol 
(DTT) (final concentration = 100 mM) were added to the extracted proteins and the samples were boiled for 10 
min. Bromophenol blue (1 µL of a 50% [w/v] solution) was added and proteins were resolved by denaturing 
sodium dodecyl sulfate – polyacrylamide gel electrophoresis (SDS-PAGE) with a 5% stacking and 8% 
resolving acrylamide gels in a 0.1% SDS, 25 mM Tris-HCl, 192 mM glycine buffer. Following fractionation, 
proteins were electrophoretically transferred to a nitrocellulose membrane (Protran, BA83; Schleicher & 
Schuell, Keene, NH) in 20% methanol, 0.1% SDS, 25 mM Tris-HCl, and 192 mM glycine for 3 h at 60 V. 
 
Membranes were blocked with 5% low-fat powdered milk in Trisbuffered saline with Tween (TBST: 0.1% 
Tween, 150 mM NaCl, 20 mM TrisHCl) containing 0.1% gelatin (type B from bovine skin; Sigma, St. Louis, 
MO). GS proteins were detected with a monoclonal antibody (Chemicon, Temecula, CA) diluted to 1 : 2000, 
followed by incubation with a horseradish peroxidase conjugated goat anti-mouse secondary antibody diluted to 
1 : 2000 (Kirkegaard and Perry Laboratories, Gaithersburg, MD), both in TBST and 5% milk for 1 h. Protein 
bands were visualized with the Renaissance-enhanced chemiluminescence system (New England Nuclear, 
Boston, MA). The autoradiograms were quantified by densitometry scanning in conjunction with the TINA 
v2.09e computer program (Raytest USA, Inc., Wilmington, NC). 
 
GSH-Level Determination 
Tissue samples (50–100 mg) were homogenized in 1 mL of 10% (v/v) perchloric acid containing 1 mM 
bathophenanthroline disulfonic acid (BPDS) and L-γ-glutamyl-L-glutamate. The mixture was vortexed and cen-
trifuged, and an aliquot was removed for high-performance liquid chromatography (HPLC) analysis (24) with a 
Waters model 600E multisolvent delivery system using an ion-exchange method with a methanol–acetate 
mobile phase and gradient elution. The limit of GSH detection was approx 50 pmol, which equated to approx 
0.4 nmol/mg protein (25,26). 
 
Statistical Analysis 
To determine statistical significance between experimental groups, one-way analysis of variance (ANOVA) was 
used. When the overall significance resulted in rejection of the null hypothesis (p < 0.05), we utilized Dunnett’s 
procedure to determine which manganese exposure levels differed from controls within each parameter 
analyzed. All analyses were performed using GraphPad InStat version 3.02 for Windows (GraphPad Software, 




The GS protein levels were significantly elevated in the hippocampus and decreased in the hypothalamus of 
young males exposed to manganese phosphate (see Table 1). In old males, GS protein levels were significantly 
decreased upon exposure to the low and medium doses of MnSO4 in the hippocampus and only the medium 
dose of MnSO4 in the hypothalamus. Female rats exposed to the medium dose of MnSO4 had a statistically 
significant decrease GS protein levels in the hippocampus and increased levels in the olfactory bulb of females 





The GS mRNA levels were significantly decreased in the cerebellum of all young males that were exposed to 
manganese, in the olfactory bulb upon exposure to the low and medium doses of MnSO4, and in the hip-
pocampus upon exposure to the high dose of MnSO4 (see Table 2). Old males that were exposed to the low dose 
of MnSO4 had a statistically significant decrease in GS mRNA in the hypothalamus, whereas those exposed to 
the high dose of MnSO4 had a statistically significant decrease in GS mRNA in the hippocampus. The female 
rats exposed to manganese phosphate had a statistically significant increase in GS mRNA levels in the 
hypothalamus (see Table 2). 
 
MT mRNA 
The MT mRNA levels were significantly decreased in the cerebellum of all young males that were exposed to 
manganese, in the olfactory bulb upon exposure to the low and medium doses of MnSO4, and in the hip-
pocampus upon exposure to the high dose of MnSO4 (Table 3). In the old males, MT mRNA was significantly 
decreased in the olfactory bulb and hippocampus upon exposure to the medium dose of manganese phosphate 
and medium and high doses of MnSO4, respectively. Finally, the female rats exposed to the high dose of 





All four manganese treatments significantly decreased GSH levels in the olfactory bulb of young male rats (see 
Table 4). Female rats exposed to all levels of manganese had significant reductions in GSH levels in the 
striatum compared to controls, but had significantly elevated levels of GSH in the olfactory bulb in those 
exposed to the medium and high doses of MnSO4. Old male rats exposed to low, medium, and high doses of 
MnSO4 had a statistically significant decrease in GSH levels in the striatum, whereas the high dose of MnSO4 
and manganese phosphate exposure caused a statistically significant decrease in GSH levels in the cerebellum. 
Finally, in the senescent male rats, the manganese phosphate treatment caused significantly decreased GSH 
levels in the hypothalamus (see Table 4). 
 
DISCUSSION 
The current inhalation reference concentration (RfC) for manganese, as set by the United States Environmental 
Protection Agency, is 0.05 μg Mn/m
3
 (27). Thus, the concentrations of manganese used in this study were 200, 
2000, and 10,000 times this standard for the low, medium (both sulfate and phosphate), and high doses, 
respectively. The accumulation of manganese in three brain regions from exposed rats was assessed, and the 
relative concentrations revealed that the olfactory bulb accumulated the most manganese, followed by the 
striatum, and then the cerebellum for young male and female rats, as well as the senescent males (22). Although 
the pattern of manganese accumulation was similar, there was a marked difference in brain regional manganese 
concentrations among the three groups (22). 
 
Specifically, the old male and young female rats had a significant increase in olfactory bulb manganese 
concentrations as a result of manganese exposure, but only the aged males exposed to the high dose of MnSO4 
had statistically increased manganese concentrations in the striatum and cerebellum and not the female rats (22). 
Exposure to the 0.1-mg Mn/m
3
 level of manganese phosphate caused a significant increase in manganese 
concentrations in the olfactory bulb of young and old males, but not female rats. Furthermore, this exposure did 
not cause significant increases in manganese concentration in the striatum or cerebellum in any of the tested 
groups. Manganese concentrations of the hypothalamus and hippocampus were not measured in this study (22). 
 
One can detect the presence of oxidants by measuring species that are known to increase or decrease in response 
to oxidative stress. This includes ubiquitous antioxidants, such as GSH, as well as species that are more specific 
to particular tissue types (e.g., glutamine synthetase [GS]). In the central nervous system (CNS), GS is localized 
exclusively in astrocytes (28), where it has a critical role in amino acid metabolism. GS metabolizes glutamate 
that is removed by astrocytes from the extracellular space to glutamine, and the latter is recycled to neurons as 
part of the glutamate–glutamine cycle (29). GS is highly susceptible to oxidation and subsequent rapid 
degradation; therefore, it serves as an excellent marker for the presence of reactive oxygen species in the brain 
(30). 
 
The results of this study showed that GS protein levels increased considerably in the hippocampus of 
manganese phosphate-exposed young male rats (see Table 1). Conversely, manganese exposure caused a 
dramatic decrease in GS protein in the hypothalamus of these rats (see Table 1). Although manganese 
concentration was not assessed in these two brain regions, there was no effect of increased manganese on GS 
protein levels in the cerebellum and olfactory bulb of young male rats in which manganese concentrations 
increased because of exposure (22). Female rats exposed to the high dose of MnSO4 had significantly increased 
GS protein in the olfactory bulb even without concomitant increases in manganese levels, whereas the aged 
male rats exposed to the medium dose of MnSO4 had a statistically significant decrease in GS protein in the 
hippocampus and hypothalamus (see Table 1). Analogous to the young male rats, there was no correlation 
between the brain regions that accumulated manganese in the old rats and the noted alterations in GS protein 
levels in these rats. Corroborating earlier findings (19,20), the GS mRNA levels (see Table 2) measured in this 
study was not reflected in GS protein (i.e., brain regions that had increased mRNA levels did not have increased 
protein levels). 
 
The MTs are a class of highly conserved proteins known to bind metals, but in recent years, evidence has shown 
that they might also have some important antioxidant properties (31). It has been suggested that MTs can 
neutralize reactive oxygen species through oxidative release of zinc from MT thiolate clusters (32). In vitro 
experiments demonstrated that MTs had a greater ability at scavenging oxygen radicals when compared with 
other sulfhydryl-containing molecules (33). Furthermore, when two different mitochondrial-specific reactive 
oxygen species generators were applied to cultured cells, MTs increased more than GSH, Mn-SOD (superoxide 
dismutase), catalase, and other well-known antioxidants (34). As with GS mRNA levels, we found that MT 
mRNA levels were significantly decreased in the cerebellum, hippocampus, and olfactory bulb of exposed 
young male rats (see Tables 2 and 3, respectively). The female rats had significantly decreased MT mRNA 
levels in the hypothalamus because of the high dose of MnSO4, whereas old male rats had a dose-dependent 
decrease in MT mRNA in the hippocampus (see Table 3). 
 
Glutathione is a ubiquitous antioxidant formed from three amino acids (glutamate, cysteine, and glycine [γ-
glutamylcysteinylglycine]). It constitutes approx 90% of the intracellular nonprotein thiols (35) and functions in 
conjugation and elimination of toxic molecules, thereby maintaining cellular redox homeostasis (35). In this 
study, GSH levels were significantly lowered in the striatum of female and old male rats upon manganese 
exposure (see Table 4). This effect was absent in the young male rats, which is consistent with our previous 
study (19). Our data support the findings of a previous study that showed decreased GSH levels in the striatum 
of aged rats exposed to manganese chloride (21). It has been reported that there is an age-dependent decrease in 
dopaminergic neurons that occurs with aging (36). Therefore, there are fewer “reserve” neurons in the striatum 
of old rats to maintain GSH homeostasis during manganese exposure. Another possibility is that GSH peroxi-
dase activity is increased under these conditions, which could cause decreased tissue GSH levels. This effect is 
a plausible explanation for the statistically significant decrease in GSH in the striatum of manganese-exposed 
young female rats, a brain region that is reportedly unaffected by manganese in young male rats (19,20). It has 
been shown that sex hormones regulate GSH-dependent enzymes in rats (e.g., GSH peroxidase activity is 
increased in brain tissue when progesterone levels are high) (37). This paradoxical effect of manganese 
exposure is potentially the results of differences in sex hormone levels between the females and males (36). 
In conclusion, we report for the first time the consequences of airborne manganese exposure on end points of 
oxidative stress in young female and old male rats. The data suggest an effect of manganese on end points of 
oxidative stress that are both age dependent and sex dependent. The striatum is a prime example of this 
observation, for both this study and previous studies (19,20) have shown that manganese exposure in young 
male rats has no effect on markers of oxidative stress. However, both female and aged rats responded to the 
same manganese exposure with a significant reduction in striatal GSH levels. These data illustrate the 
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